Showing 17,241 - 17,260 results of 29,492 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((nm decrease) OR (nn decrease)) ))', query time: 0.57s Refine Results
  1. 17241

    Detection of glycan-dependent HIV-1 neutralizing antibodies in sera from LTNPs and typical progressors. by Nuria González (4532422)

    Published 2018
    “…Percent serum neutralizing activity sensitive to the indicated residue replacement was calculated using the equation [1 − (ID50 mutant/ID50 wild type)] x 100. A sample is considered positive if there is a decrease in ID50 greater than or equal to 50% for the mutant relative to the wild-type virus. …”
  2. 17242

    Effects of DA on the I<sub>Na</sub>. by Catalina Valdés-Baizabal (701863)

    Published 2015
    “…The data were fitted with a concentration response curve (solid line) with an IC<sub>50</sub> of 2.5 x 10<sup>–6</sup> M and a Hill coefficient of 1. …”
  3. 17243

    Combined treatment of CAPE with chemotherapy drugs shows synergistic and antagonistic inhibition on proliferation of PC-3 cells. by Hui-Ping Lin (184894)

    Published 2012
    “…For example, treatment of 5 µM of CAPE or 1 nM vinblastine decreases cell number of PC-3 to 80.9% and 88.7%, respectively, compared to the control (no treatment). …”
  4. 17244

    Heterotrophic cell growth and dry cell yield of <i>Rhodovulum sulfidophilum</i> in artificial seawater (ASW) based growth medium of different salinities, wherein 100% corresponds t... by Shamitha Rao Morey-Yagi (19779981)

    Published 2025
    “…<p><b>a,</b> Growth curve and <b>b,</b> dry cell yield (g L<sup>-1</sup>) of <i>R. sulfidophilum</i> in ASW supplemented with 0.1% yeast extract and 0.5% peptone, and <b>c,</b> dry cell yield (g L<sup>-1</sup>) of <i>R. sulfidophilum</i> in ASW supplemented with 1 mM sodium acetate and 2.5 mM sodium thiosulfate in decreasing concentrations of ASW, i.e., 100%, 90%, 80%, 70%, 60%, and 50% which correspond to 3%, 2.7%, 2.4%, 2.1%, 1.8%, and 1.5% salinities respectively. …”
  5. 17245
  6. 17246
  7. 17247

    Table 1_Biochar of hazelnut shell mitigates cadmium toxicity in forage soybean.xlsx by Sedat Severoğlu (22489270)

    Published 2025
    “…Compared to the B0Cd0 treatment, the B0Cd1, B0Cd2, and B0Cd3 treatments resulted in 45, 62 and 67% decrease in shoot fresh weight (SFW), 37, 46 and 50% decrease in shoot dry weight (SDW), 31, 45 and 56% in root fresh weight (RFW), 34, 50 and 59% in root dry weight (RDW), and 13, 29 and 40% de-crease in LA. …”
  8. 17248

    Cell viability in HepG2 cells: HepG2 cells were pre-treated with lovastatin for 24h before everolimus was added, and the combination of both drugs was incubated for 48h (A) or 120h... by Svenja Nölting (566453)

    Published 2015
    “…(B) Treatment with 5–20 μM lovastatin or with 10 nM everolimus separately significantly decreased HepG2 cell viability. …”
  9. 17249

    Electrochemiluminescence Properties of [Pt<sub>2</sub>Ag<sub>4</sub>(CCC<sub>6</sub>H<sub>4</sub>R)<sub>8</sub>]<sub><i>n</i></sub> (R = CH<sub>3</sub>, <i>n</i> = 1; R = H, <i>n<... by Qiao-Hua Wei (1915426)

    Published 2012
    “…A considerable enhancement of photoluminescence (PL) and a notable red shift in the emission maximum of <b>1</b> (λ<sub>max</sub> 600 nm) relative to <b>2</b> (λ<sub>max</sub> 545 nm) are observed. …”
  10. 17250

    Baicalin ameliorates chronic mild stress-induced depression-like behaviors in mice and attenuates inflammatory cytokines and oxidative stress by Juying Zhong (6878816)

    Published 2019
    “…This study evaluated the behavioral and neuroprotective effects of BA in mice subjected to chronic unpredictable mild stress, a model of depression. BA (25 and 50 mg/kg) significantly increased sucrose consumption and reduced immobility times in the tail suspension and forced swim tests, demonstrating that BA alleviated depression-like behaviors. …”
  11. 17251

    Table_1_Distinct Seasonal Primary Production Patterns in the Sub-Polar Gyre and Surrounding Seas.XLSX by Katherine Richardson (3198477)

    Published 2021
    “…Multi-model Earth System model studies have indicated that climate change may decrease the MLD in the sub-polar gyre and suggest this may lead to a decrease in the PP occurring here. …”
  12. 17252

    Anti-inflammatory effects of DHA in the infected gastric mucosa of mice. by Marta Correia (170478)

    Published 2012
    “…<p><b>A</b>) Histological analysis of inflammatory lesions of the gastric mucosa of <i>H. pylori</i> infected or non-infected mice treated or not with DHA 50 µM after 6 and 9 months. …”
  13. 17253
  14. 17254

    Effect of FAAH inhibition on depressive-like behavior in WKY rats. by K. Yaragudri Vinod (323103)

    Published 2013
    “…<p>Treatment with URB597 (0.3 mg/kg, i.p. for 7 days) elicited a significant decrease in total time spent in immobility (50%, p<0.01; A) and a marked increase in sucrose intake (48%, p<0.05; B) without any effect on the spontaneous locomotor activity in the open field (C) in WKY rats compared to vehicle treated WKY rats.…”
  15. 17255

    iGP-1 is cell-permeant and inhibits mGPDH in intact presynaptic terminals. by Adam L. Orr (526725)

    Published 2014
    “…(<b>F</b>) iGP-1 fluorescence as a function of buffer pH (ex. λ = 342 nm, em. λ = 430 nm). (<b>G</b>) Effect of vehicle control (DMSO, <i>white bars</i>), 100 µM iGP-1 (<i>light gray bars</i>), 0.5 mM aminooxyacetate (<i>dark gray bars</i>), or their combination (<i>black bars</i>) on synaptosomal respiration. …”
  16. 17256
  17. 17257
  18. 17258
  19. 17259

    Purification and characterization of the deletion mutants. by Amanda Jack (11547638)

    Published 2021
    “…<b>(C)</b> EMSA gels using no RNA, 10 nM 0–5 kb viral RNA, or 50 ng/μL polyC RNA and decreasing concentration of the ΔR2 mutant. …”
  20. 17260

    Table_1_The Metabolic Changes and Immune Profiles in Patients With COVID-19.pdf by Bing He (135034)

    Published 2020
    “…<p>To explore the metabolic changes and immune profiles in patients with COVID-19, we analyzed the data of patients with mild and severe COVID-19 as well as young children with COVID-19. …”